NCT00137579View on ClinicalTrials.gov

Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation Therapy

PHASE4CompletedINTERVENTIONAL

Enrollment

216

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

May 31, 2004

Conditions

Influenza

Interventions

PROCEDURE

Influenza vaccine intramuscular administration route

Trial Locations (4)

08001

Raval Nord, Barcelona

Raval Sud, Barcelona

08002

Gotic, Barcelona

08003

Casc Antic, Barcelona

All Listed Sponsors

lead

Catalan Institute of Health

OTHER_GOV

NCT00137579 - Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation Therapy | Biotech Hunter | Biotech Hunter